Font Size: a A A

Research On Financing Problems Of KYT

Posted on:2020-05-08Degree:MasterType:Thesis
Country:ChinaCandidate:Y Q JiFull Text:PDF
GTID:2439330572977196Subject:Business Administration
Abstract/Summary:PDF Full Text Request
With the gradual improvement of the capital market,it is an inevitable choice for enterprises to maintain simple reproduction and expand reproduction through financing.However,the assets of SMEs are usually small,since their weaker anti-risk ability compared with the large enterprises.The insufficient use of financing channels,high financing costs,and widespread financing constraints have severely restricted the development of SMEs.As a typical SMEs in Shandong,the economic development of KYT Pharmaceutical Company has a good demonstration effect on the development of other SMEs.Therefore,solving the financing problem of KYT can surely promote the rapid and healthy development of enterprises in the capital market,and means a lot for promoting the development of SMEs in ShandongIn order to solve the financing problems of KYT pharmaceutical industry,the field research and statistical analysis are used for in-depth research and analysis.First of all,this paper mainly describes the related concepts and references to the relevant theory,to provide theoretical support for the whole study.Secondly,the development status of KYT pharmaceutical company was reviewed in detail from three aspects including the company's basic situation,main business and financial capacity.The financing status of KYT pharmaceutical company was described from three perspectives including financing channels,financing scale and financing structure.Then,in-depth research and analysis on the current development concludes that KYT Pharmaceutical Company has four key issues in the financing process,including people too reliant on bank loans,financing structure imbalance,the new three board equity financing channels with insufficience,financial management and finance management loophole and small scale enterprise financing constraints.At the same time,several problems existing in financing of KYT pharmaceutical company were pointed out,and the corresponding reasons were found,including ignoring the importance of financing structure,lack of necessary openness of share capital,waiting to be improved standardization of company management,and lack of strong strategic investors.Finally draw lessons from other new three board listed companies financing experience and the actual situation of enterprises,put forward the strategy to solve the problem of KYT pharmaceutical company financing options,recommend to adjust and broaden the financing channels,financing from private financing to public offering ascension equity open-ended and enhance the level of financial internal control and financial management,introduction of strategic investors to expand the scale of the company: strengthening the construction of corporate credit,etc.The purpose of this paperis to provide specific solutions for improving KYT's financing status through researches in related fields,and provide experience for other SMEs with similar situations in dealing with financing problems.
Keywords/Search Tags:Financing constraints, Debt financing, Equity financing, Financing channels, Capital structure
PDF Full Text Request
Related items